Stockscreener 앱 받기
55.17
0.18%
0.10
시간 외 거래:
55.18
0.010
+0.02%
Xenon Pharmaceuticals Inc 주식(XENE)의 최신 뉴스
Xenon Pharmaceuticals Shares Jump 20% Over Three Months: The Reasons Explained - Bitget
Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why - Yahoo Finance
Investors Buy High Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - MarketBeat
Xenon Pharmaceuticals (XENE) Is Down 6.7% After $650 Million Follow-On Offering And Phase 3 Epilepsy Win - Yahoo Finance
Assessing Xenon Pharmaceuticals (XENE) Valuation After Positive Phase 3 X TOLE2 Azetukalner Results - simplywall.st
XENE stock up as Azetukalner meets goal in focal onset seizures study - MSN
XENE Technical Analysis & Stock Price Forecast - Intellectia AI
Jain Global LLC Takes Position in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Xenon Pharmaceuticals Inc. $XENE Shares Sold by Granahan Investment Management LLC - MarketBeat
Holocene Advisors LP Acquires 167,078 Shares of Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Cinctive Capital Management LP Takes Position in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Xenon Pharmaceuticals Inc. $XENE Shares Sold by Bamco Inc. NY - MarketBeat
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Rating of "Buy" by Brokerages - MarketBeat
XENE: Wedbush Adjusts Target Price for Xenon Pharmaceuticals | X - GuruFocus
Xenon Pharmaceuticals (NASDAQ:XENE) Price Target Cut to $63.00 by Analysts at Wedbush - MarketBeat
Wedbush lowers Xenon Pharmaceuticals stock price target to $63 - Investing.com
HighVista Strategies LLC Increases Stock Holdings in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
5 Stocks Making Huge Moves this Week - Insider Monkey
Xenon Pharmaceuticals (XENE) Climbs 31.7% as Epilepsy Treatment Moves Forward - Insider Monkey
Commodore Capital LP Has $108.41 Million Position in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Xenon Sets Date for 2026 Annual Shareholder Meeting - The Globe and Mail
Xenon Pharmaceuticals Inc. Announces 2026 Annual Meeting of Shareholders Details and Notice Procedures - Minichart
Christopher John Kenney Sells 1,410 Shares of Xenon Pharmaceuticals (NASDAQ:XENE) Stock - MarketBeat
Xenon Pharmaceuticals (NASDAQ:XENE) CEO Sells $403,620.84 in Stock - MarketBeat
Xenon Pharmaceuticals (NASDAQ:XENE) Insider Andrea Difabio Sells 1,342 Shares - MarketBeat
XENE (NASDAQ: XENE) Rule 144 Notice — 3,750 RSUs Vesting - Stock Titan
Ian Mortimer sells 270,000 XENE shares; multiple disposals (NASDAQ: XENE) - Stock Titan
Xenon Pharmaceuticals closes $747.5M public offering By Investing.com - Investing.com Australia
Xenon Strengthens Balance Sheet With Major Equity Offering - The Globe and Mail
symbol__ Stock Quote Price and Forecast - CNN
Finance Watch: As IPO Market Quiets Again, Xenon, Dianthus Price Big Follow-Ons - Citeline News & Insights
Xenon Pharmaceuticals (XENE) sets June 2, 2026 annual shareholder meeting and April 7 record date - Stock Titan
Xenon Pharmaceuticals closes $747.5M public offering - Investing.com Nigeria
Xenon’s X-TOLE2 Trial Completion Puts XEN1101 in Focus for Epilepsy Investors - TipRanks
Xenon Pharmaceuticals (XENE) CEO reports RSU vesting and 7,308-share tax sale - Stock Titan
Xenon Pharmaceuticals closes US $747.5M public offering - Private Capital Journal
Assessing Xenon Pharmaceuticals (XENE) Valuation After A Sharp Recent Share Price Surge - Yahoo Finance
BofA raises Xenon Pharmaceuticals price target on trial success - Investing.com South Africa
BofA raises Xenon Pharmaceuticals price target on trial success By Investing.com - Investing.com Canada
Xenon Pharmaceuticals Closes $747.5 Million Public Offering - marketscreener.com
Xenon Pharmaceuticals Nets $707.7 Million in $57 Share Offering With Pre-Funded Warrants - TradingView
Xenon Pharmaceuticals (NASDAQ: XENE) prices $707.7M equity raise - Stock Titan
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares - GlobeNewswire
Xenon Pharmaceuticals launches $500 million stock offering By Investing.com - Investing.com Nigeria
The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE) - The Chronicle-Journal
Xenon Pharmaceuticals (NASDAQ: XENE) offers 10.5M shares and 877K warrants for $615M - Stock Titan
Is Xenon Pharmaceuticals (XENE) Pricing Look Compelling After Recent 37% Weekly Share Surge? - simplywall.st
What is HC Wainwright's Estimate for XENE FY2027 Earnings? - MarketBeat
Atika Capital Management LLC Invests $1.53 Million in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Xenon Pharmaceuticals shares jump 40% after strong Phase 3 seizure trial results - MSN
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares - Bitget
Xenon Raises $650 Million in Upsized U.S. Equity Offering - The Globe and Mail
Ian Mortimer Sells 11,269 Shares of Xenon Pharmaceuticals (NASDAQ:XENE) Stock - MarketBeat
Xenon Pharmaceuticals (NASDAQ:XENE) CEO Ian Mortimer Sells 270,000 Shares - MarketBeat
Insider Selling: Xenon Pharmaceuticals (NASDAQ:XENE) Insider Sells 2,771 Shares of Stock - MarketBeat
Xenon Pharmaceuticals (NASDAQ:XENE) Insider Sells $156,706.77 in Stock - MarketBeat
XENE Expands Stock Offering to $650 Million - GuruFocus
Xenon Pharmaceuticals (XENE) CMO vests 7,500 PSUs, sells 2,771 shares for taxes - Stock Titan
Xenon Pharmaceuticals (XENE) CLO sells shares to cover PSU taxes - Stock Titan
Xenon Pharmaceuticals (XENE) CEO exercises 290,000 options and sells shares under 10b5-1 plans - Stock Titan
Xenon Pharmaceuticals prices $650M public offering at $57/share - Investing.com Australia
Xenon Pharmaceuticals prices $650M public offering at $57/share By Investing.com - Investing.com Nigeria
Xenon Pharmaceuticals (NASDAQ:XENE) Sees Large Volume Increase on Analyst Upgrade - MarketBeat
Xenon Pharmaceuticals Prices Upsized $650 Million Public Offering of Shares - marketscreener.com
Liquidity Mapping Around (XENE) Price Events - Stock Traders Daily
Xenon Pharmaceuticals (XENE) Upsizes Public Offering to $650 Mil - GuruFocus
1.20%
0.06%
자본화:
|
볼륨(24시간):